Clinical Trial Update: A Study of Pertuzumab in Participants With Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Pertuzumab in metastatic breast cancer has completed, with results posted on August 25, 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Pertuzumab (pertuzumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2015-08-25